Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot StudyElizabeth A. Raetz, Peter C. Adamson, Mitchell S. Cairo et al.|Journal of Clinical Oncology|2008Cited by 210
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trialSima Jeha, C‐H Pui, Violet Shen et al.|Leukemia|2004Cited by 180
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Yanhua Zhao et al.|Cancer Discovery|2021Cited by 90
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium studyLars M. Wagner, Peter C. Adamson, John P. Perentesis et al.|Pediatric Blood & Cancer|2010Cited by 73
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium studyLindsay Kilburn, Susan M. Blaney|Neuro-Oncology|2014Cited by 14